Skip to main content
Premium Trial:

Request an Annual Quote

BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB

NEW YORK – Opko Health's BioReference Laboratories on Thursday announced an agreement with Major League Baseball to provide COVID-19 testing for the 2021 season.

The Elmwood Park, New Jersey-based firm will provide on-site, rapid PCR, point-of-care testing for all 30 teams in MLB using Mesa Biotech's Accula system, which received Emergency Use Authorization from the US Food and Drug Administration a year ago.

Testing begins on Thursday, the start of the 2021 MLB season.

The company is "now supporting all five major professional men's sports leagues in the United States in safely moving forward with their seasons," BioReference Executive Chairman Jon Cohen said in a statement.

On the firm's Q4 financial results conference call in February, it emphasized the continued need for rapid, POC testing for SARS-CoV-2 and noted that the uptake of BioReference's custom POC services has been sharpest in sports leagues.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.